| In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium MA Rosenfeld, K Yoshimura, BC Trapnell, K Yoneyama, ER Rosenthal, ... Cell 68 (1), 143-155, 1992 | 1311 | 1992 |
| Efficacy and safety of sirolimus in lymphangioleiomyomatosis FX McCormack, Y Inoue, J Moss, LG Singer, C Strange, K Nakata, ... New England Journal of Medicine 364 (17), 1595-1606, 2011 | 1171 | 2011 |
| Pulmonary alveolar proteinosis BC Trapnell, JA Whitsett, K Nakata New England Journal of Medicine 349 (26), 2527-2539, 2003 | 957 | 2003 |
| Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy N Mittereder, KL March, BC Trapnell Journal of virology 70 (11), 7498-7509, 1996 | 948 | 1996 |
| GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU. 1 Y Shibata, PY Berclaz, ZC Chroneos, M Yoshida, JA Whitsett, BC Trapnell Immunity 15 (4), 557-567, 2001 | 693 | 2001 |
| Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study S Kugathasan, LA Denson, TD Walters, MO Kim, UM Marigorta, ... The Lancet 389 (10080), 1710-1718, 2017 | 582 | 2017 |
| Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA CS Chu, BC Trapnell, S Curristin, GR Cutting, RG Crystal Nature genetics 3 (2), 151-156, 1993 | 577 | 1993 |
| Diffuse lung disease in young children: application of a novel classification scheme GH Deutsch, LR Young, RR Deterding, LL Fan, SD Dell, JA Bean, ... American journal of respiratory and critical care medicine 176 (11), 1120-1128, 2007 | 570 | 2007 |
| Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan Y Inoue, BC Trapnell, R Tazawa, T Arai, T Takada, N Hizawa, Y Kasahara, ... American journal of respiratory and critical care medicine 177 (7), 752-762, 2008 | 537 | 2008 |
| Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug … DJ Hassett, J Cuppoletti, B Trapnell, SV Lymar, JJ Rowe, SS Yoon, ... Advanced drug delivery reviews 54 (11), 1425-1443, 2002 | 434 | 2002 |
| Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense BC Trapnell, JA Whitsett Annual review of physiology 64 (1), 775-802, 2002 | 423 | 2002 |
| Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice TAG Smith, MG Mehaffey, DB Kayda, JM Saunders, S Yei, BC Trapnell, ... Nature genetics 5 (4), 397-402, 1993 | 414 | 1993 |
| Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α1-Antitrypsin: Interim Results TR Flotte, BC Trapnell, M Humphries, B Carey, R Calcedo, F Rouhani, ... Human gene therapy 22 (10), 1239-1247, 2011 | 392 | 2011 |
| GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis K Uchida, DC Beck, T Yamamoto, PY Berclaz, S Abe, MK Staudt, ... New England Journal of Medicine 356 (6), 567-579, 2007 | 328 | 2007 |
| Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA T Suzuki, T Sakagami, BK Rubin, LM Nogee, RE Wood, SL Zimmerman, ... The Journal of experimental medicine 205 (12), 2703-2710, 2008 | 321 | 2008 |
| Pulmonary macrophage transplantation therapy T Suzuki, P Arumugam, T Sakagami, N Lachmann, C Chalk, A Sallese, ... Nature 514 (7523), 450-454, 2014 | 316 | 2014 |
| Alveolar macrophages release an insulin-like growth factor I-type molecule. WN Rom, P Basset, GA Fells, T Nukiwa, BC Trapnell, RG Crysal The Journal of clinical investigation 82 (5), 1685-1693, 1988 | 316 | 1988 |
| Pulmonary alveolar proteinosis BC Trapnell, K Nakata, F Bonella, I Campo, M Griese, J Hamilton, T Wang, ... Nature Reviews Disease Primers 5 (1), 16, 2019 | 290 | 2019 |
| Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection JP Clancy, L Dupont, MW Konstan, J Billings, S Fustik, CH Goss, J Lymp, ... Thorax 68 (9), 818-825, 2013 | 289 | 2013 |
| Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. BC Trapnell, CS Chu, PK Paakko, TC Banks, K Yoshimura, VJ Ferrans, ... Proceedings of the National Academy of Sciences 88 (15), 6565-6569, 1991 | 277 | 1991 |
Koh NakataDivision of Pioneering Advanced Therapeutics Niigata University Medical & Dental Hospital在 med.niigata-u.ac.jp 的电子邮件经过验证
